150 related articles for article (PubMed ID: 7258222)
1. A unique patient with coexisting cerebrotendinous xanthomatosis and beta-sitosterolemia.
Wang C; Lin HJ; Chan TK; Salen G; Chan WC; Tse TF
Am J Med; 1981 Aug; 71(2):313-9. PubMed ID: 7258222
[TBL] [Abstract][Full Text] [Related]
2. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis.
Kuriyama M; Fujiyama J; Kasama T; Osame M
J Lipid Res; 1991 Feb; 32(2):223-9. PubMed ID: 2066659
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.
Salen G; Kwiterovich PO; Shefer S; Tint GS; Horak I; Shore V; Dayal B; Horak E
J Lipid Res; 1985 Feb; 26(2):203-9. PubMed ID: 3989379
[TBL] [Abstract][Full Text] [Related]
4. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters.
Bhattacharyya AK; Connor WE
J Clin Invest; 1974 Apr; 53(4):1033-43. PubMed ID: 4360855
[TBL] [Abstract][Full Text] [Related]
5. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
6. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis.
Salen G; Horak I; Rothkopf M; Cohen JL; Speck J; Tint GS; Shore V; Dayal B; Chen T; Shefer S
J Lipid Res; 1985 Sep; 26(9):1126-33. PubMed ID: 4067433
[TBL] [Abstract][Full Text] [Related]
7. Beta-Sitosterolemia and xanthomatosis.
Nutr Rev; 1976 Jun; 34(6):172-4. PubMed ID: 781555
[No Abstract] [Full Text] [Related]
8. [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)].
Wolf LM; Houdent C; Laudat MH; Brasseur G; Balacheff O; Uzac L
Nouv Presse Med; 1982 Mar; 11(11):855-7. PubMed ID: 7070978
[TBL] [Abstract][Full Text] [Related]
9. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7 alpha-hydroxylase.
Shefer S; Salen G; Nguyen L; Batta AK; Packin V; Tint GS; Hauser S
J Clin Invest; 1988 Dec; 82(6):1833-9. PubMed ID: 3143743
[TBL] [Abstract][Full Text] [Related]
10. Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues.
Connor WE; Lin DS; Pappu AS; Frohlich J; Gerhard G
Lipids; 2005 Sep; 40(9):919-23. PubMed ID: 16331855
[TBL] [Abstract][Full Text] [Related]
11. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis.
Hidaka H; Nakamura T; Aoki T; Kojima H; Nakajima Y; Kosugi K; Hatanaka I; Harada M; Kobayashi M; Tamura A
J Lipid Res; 1990 May; 31(5):881-8. PubMed ID: 2380636
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
[TBL] [Abstract][Full Text] [Related]
14. Spinal cord compression with paraplegia in xanthomatosis due to normocholesterolemic sitosterolemia.
Hatanaka I; Yasuda H; Hidaka H; Harada N; Kobayashi M; Okabe H; Matsumoto K; Hukuda S; Shigeta Y
Ann Neurol; 1990 Sep; 28(3):390-3. PubMed ID: 2241122
[TBL] [Abstract][Full Text] [Related]
15. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis.
Salen G; Shore V; Tint GS; Forte T; Shefer S; Horak I; Horak E; Dayal B; Nguyen L; Batta AK
J Lipid Res; 1989 Sep; 30(9):1319-30. PubMed ID: 2600539
[TBL] [Abstract][Full Text] [Related]
16. Normolipemic tendon and tuberous xanthomas.
Fleischmajer R; Tint GS; Bennett HD
J Am Acad Dermatol; 1981 Sep; 5(3):290-6. PubMed ID: 7263974
[TBL] [Abstract][Full Text] [Related]
17. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.
Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S
N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
Kuriyama M; Tokimura Y; Fujiyama J; Utatsu Y; Osame M
J Neurol Sci; 1994 Aug; 125(1):22-8. PubMed ID: 7964884
[TBL] [Abstract][Full Text] [Related]
19. beta-Sitosterolemia with generalized eruptive xanthomatosis.
Hidaka H; Sugiura H; Nakamura T; Kojima H; Fujita M; Sugie N; Okabe H; Nishio Y; Maegawa H; Kashiwagi A; Kikkawa R
Endocr J; 1997 Feb; 44(1):59-64. PubMed ID: 9152615
[TBL] [Abstract][Full Text] [Related]
20. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
